scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1053365064 |
P356 | DOI | 10.1007/S13277-015-4121-8 |
P698 | PubMed publication ID | 26493994 |
P2093 | author name string | Zhigang Liu | |
Haifeng Sun | |||
Zheng Zhao | |||
Chengxue Dang | |||
Wenjuan Chen | |||
Zijun Liao | |||
Zhangjun Song | |||
Baoxia Lei | |||
P2860 | cites work | Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. | Q50926584 |
Chronic versus acute myelogenous leukemia: a question of self-renewal. | Q52062147 | ||
Stromal niche cells protect early leukemic FLT3-ITD+ progenitor cells against first-generation FLT3 tyrosine kinase inhibitors. | Q54592057 | ||
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons | Q71235390 | ||
An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcome | Q82296672 | ||
The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study | Q86499705 | ||
A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells | Q24310281 | ||
Identification of c-MYC as a target of the APC pathway | Q24310637 | ||
Human pyruvate kinase M2: a multifunctional protein | Q24625882 | ||
Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
Stem cells, cancer, and cancer stem cells | Q27860878 | ||
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
Cancer stem cells: mirage or reality? | Q28257690 | ||
Identification of pancreatic cancer stem cells | Q28286997 | ||
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells | Q28294874 | ||
Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network | Q28513471 | ||
Tumour stem cells and drug resistance | Q29617742 | ||
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
Pyruvate kinase isozymes in neurons, glia, neuroblastoma, and glioblastoma | Q33852866 | ||
Wnt signaling in cancer | Q34262857 | ||
L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases | Q34341011 | ||
Three clonal types of keratinocyte with different capacities for multiplication | Q34393745 | ||
Telomerase and cancer stem cells | Q34569385 | ||
Wnt/catenin signaling in adult stem cell physiology and disease | Q34959673 | ||
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression | Q35679187 | ||
Self-renewal and solid tumor stem cells | Q35892127 | ||
Wnt/beta-catenin pathway | Q36043253 | ||
Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis | Q36154999 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
Notch Signaling in the Regulation of Stem Cell Self-Renewal and Differentiation | Q37785203 | ||
The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators | Q37797633 | ||
Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming | Q37878387 | ||
Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts | Q38910999 | ||
P433 | issue | 3 | |
P304 | page(s) | 4223-4234 | |
P577 | publication date | 2015-10-22 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway | |
P478 | volume | 37 |
Q39443694 | Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack |
Q89598674 | Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer |
Q49959198 | Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN. |
Q92761067 | Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion |
Q39374497 | Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma |
Q46489215 | Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients. |
Q47094780 | Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis |
Q42339119 | Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer |
Q58607131 | Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer |
Q89667670 | Targeting cancer stem cell pathways for cancer therapy |
Search more.